The Ministry of Health of Ukraine has delayed the process of concluding contracts for the supply of Pfizer vaccines, Interfax-Ukraine quotes the CEO at Pfizer Ukraine Zoriana Tsilyk.
Negotiations on the vaccine supply are underway, but the medication itself has not yet been registered in Ukraine.
"Vaccination is a complex logistic process ... But we cannot start detailed communication until the medication is registered in Ukraine. We are doing our best to make this happen as soon as possible. All governments signed agreements back in July, [Ukraine] should have done it earlier. We are doing our best to have the vaccine in Ukraine. Negotiations are underway now—there is hope, the chances are good," she said.
Tsilyk added that for convenience, Ukrainians should introduce vaccination passports, where vaccination data will be entered.
"After all, almost all vaccines require two injections, and this needs to be tracked somehow. It would be convenient to have vaccination data on your phone if you want to travel around the world," she said.
Ukraine is on the list of countries of the first COVAX wave. Delivery of 8 million doses of coronavirus vaccines is expected. Of these, 117,000 are produced by Pfizer-BioNTech (expected before mid-February 2021), from 2.2 million to 3.8 million are produced by AstraZeneca (before the end of the Q2 of 2021). Also, a state contract was signed for the purchase of 1.9 million doses of SinoVac vaccine. In total, Ukraine should receive 15 million doses by the end of 2021.
Context. The Minister of Health Maksym Stepanov announced that vaccination against COVID-19 will begin in Ukraine on February 15, 2021. Earlier, President Volodymyr Zelensky said that he had appealed to the leaders of the EU countries\with which Ukraine has good relations. They agreed to help and give part of the vaccines to Ukraine.